Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up0.55% Nasdaq Up0.29%

Hi-Tech Pharmacal Co., Inc. (HITK)

-NasdaqGS
43.50 0.16(0.37%) Apr 15, 4:00PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJan 31, 2014Oct 31, 2013Jul 31, 2013Apr 30, 2013
Total Revenue 59,902   58,601   50,501   58,473  
Cost of Revenue27,962  27,291  25,076  31,182  
Gross Profit 31,940   31,310   25,425   27,291  
Operating Expenses
Research Development4,449  5,091  3,959  3,552  
Selling General and Administrative14,212  13,607  12,942  14,700  
Non Recurring -   -   -   -  
Others1,651  1,651  1,658  1,606  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 11,628   10,961   6,866   7,433  
Income from Continuing Operations
Total Other Income/Expenses Net752  (9,117)131  (15,606)
Earnings Before Interest And Taxes12,380  1,844  6,997  (8,173)
Interest Expense69  69  107  100  
Income Before Tax12,311  1,775  6,890  (8,273)
Income Tax Expense3,960  588  2,340  (3,656)
Minority Interest -   -   -   -  
Net Income From Continuing Ops8,351  1,187  4,550  (4,617)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 8,351   1,187   4,550   (4,617)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 8,351   1,187   4,550   (4,617)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.